Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
Authors
Keywords
Breast cancer, Tamoxifen resistance, Stem cells, Self-renewing capacity, Estrogenreceptor
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 142, Issue 3, Pages 537-548
Publisher
Springer Nature
Online
2013-11-20
DOI
10.1007/s10549-013-2760-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapies of metastatic breast cancer: Relationships with cancer stem cells
- (2013) Paola Ferrari et al. BIOMEDICINE & PHARMACOTHERAPY
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Overexpression Nanog Activates Pluripotent Genes in Porcine Fetal Fibroblasts and Nuclear Transfer Embryos
- (2011) Li Zhang et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
- (2011) Claudia Lengerke et al. BMC CANCER
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
- (2011) Ada Ao et al. PLoS One
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Effects of estrogen on the proportion of stem cells in the breast
- (2010) Bruno M. Simões et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling
- (2010) C. M. Fillmore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice
- (2008) Marina Simian et al. BREAST CANCER RESEARCH AND TREATMENT
- Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal–epithelial interactions
- (2008) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cells
- (2008) Ilaria Taddei et al. NATURE CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started